116
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Testing the anti-fibrotic potential of the single-chain Fv antibody against the α2 C-terminal telopeptide of collagen I

, , , , , , , & show all
Pages 115-122 | Received 21 Aug 2013, Accepted 01 Nov 2013, Published online: 10 Jan 2014

References

  • Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NB, Hamid M. scFv antibody: principles and clinical application. Clin Dev Immunol 2012;2012: Article ID 980250, 15 pp. doi:10.1155/2012/980250
  • Huston JS. Engineering antibodies for the 21st century. Protein Eng Des Sel 2012;25:483–4
  • Robert R, Wark KL. Engineered antibody approaches for Alzheimer's disease immunotherapy. Arch Biochem Biophys 2012;526:132–8
  • Chung HJ, Steplewski A, Chung KY, Uitto J, Fertala A. Collagen fibril formation. A new target to limit fibrosis. J Biol Chem 2008;283:25879–86
  • Fertala J, Steplewski A, Kostas J, Beredjiklian P, Williams G, Arnold W, Abboud J, Bhardwaj A, Hou C, Fertala A. Engineering and characterization of the chimeric antibody that targets the C-terminal telopeptide of the α2 chain of human collagen I: a next step in the quest to reduce localized fibrosis. Connect Tissue Res 2013;54:187–96
  • Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 2011;27:343–50
  • Kumar R. Role of naturally occurring osmolytes in protein folding and stability. Arch Biochem Biophys 2009;491:1–6
  • Kadler KE, Hojima Y, Prockop DJ. Assembly of collagen fibrils de novo by cleavage of the type I pC-collagen with procollagen C-proteinase. Assay of critical concentration demonstrates that collagen self-assembly is a classical example of an entropy-driven process. J Biol Chem 1987;262:15696–701
  • Prockop DJ, Fertala A. Inhibition of the self-assembly of collagen I into fibrils with synthetic peptides. Demonstration that assembly is driven by specific binding sites on the monomers. J Biol Chem 1998;273:15598–604
  • Myszka DG, Morton TA. CLAMP: a biosensor kinetic data analysis program. Trends Biochem Sci 1998;23:149–50
  • Fertala A, Holmes DF, Kadler KE, Sieron AL, Prockop DJ. Assembly in vitro of thin and thick fibrils of collagen II from recombinant procollagen II. The monomers in the tips of thick fibrils have the opposite orientation from monomers in the growing tips of collagen I fibrils. J Biol Chem 1996;271:14864–9
  • Hagg R, Bruckner P, Hedbom E. Cartilage fibrils of mammals are biochemically heterogeneous: differential distribution of decorin and collagen IX. J Cell Biol 1998;142:285–94
  • Kadler KE, Hojima Y, Prockop DJ. Collagen fibrils in vitro grow from pointed tips in the C- to N-terminal direction. Biochem J 1990;268:339–43
  • Malone JP, Veis A. Heterotrimeric type I collagen C-telopeptide conformation as docked to its helix receptor. Biochemistry 2004;43:15358–66
  • Bork P, Holm L, Sander C. The immunoglobulin fold. Structural classification, sequence patterns and common core. J Mol Biol 1994;242:309–20
  • Sun W, Xie J, Lin H, Mi S, Li Z, Hua F, Hu Z. A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies. Protein Expr Purif 2012;83:21–9
  • Gil D, Schrum AG. Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments. Adv Biosci Biotechnol 2013;4:73–84
  • Ward ES, Gussow D, Griffiths AD, Jones PT, Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989;341:544–6
  • Borrebaeck CA, Ohlin M. Antibody evolution beyond nature. Nat Biotechnol 2002;20:1189–90

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.